Literature DB >> 12697441

Suppression of antiviral responses by antibody-dependent enhancement of macrophage infection.

Andreas Suhrbier1, May La Linn.   

Abstract

Antibody-dependent enhancement (ADE) of macrophage and monocyte infection has been demonstrated in vitro for some of the most deadly RNA viruses known. Recent evidence suggests that ADE-mediated ligation of Fc receptors might suppress host-cell antiviral gene expression by promoting early interleukin-10 (IL-10) secretion, resulting in the expression of suppressor-of-cytokine-signalling (SOCS) proteins and a Th2 bias. These findings provide potential new insights into how ADE might enhance viral infections and exacerbate disease.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12697441     DOI： 10.1016/s1471-4906(03)00065-6

Source DB:  PubMed          Journal:  Trends Immunol        ISSN： 1471-4906            Impact factor:   16.687


  25 in total

1.  Inhibition of IFN-alpha signaling by a PKC- and protein tyrosine phosphatase SHP-2-dependent pathway.

Authors:  Zhimei Du; Yuhong Shen; Wentian Yang; Ingrid Mecklenbrauker; Benjamin G Neel; Lionel B Ivashkiv
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-06       Impact factor: 11.205

Review 2.  How innate immune mechanisms contribute to antibody-enhanced viral infections.

Authors:  Sukathida Ubol; Scott B Halstead
Journal:  Clin Vaccine Immunol       Date:  2010-09-28

Review 3.  Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection.

Authors:  Theodore C Pierson; Michael S Diamond
Journal:  Expert Rev Mol Med       Date:  2008-05-12       Impact factor: 5.600

4.  The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates.

Authors:  Natalie A Prow; Liang Liu; Mary K McCarthy; Kevin Walters; Raj Kalkeri; Jillian Geiger; Fusataka Koide; Tamara H Cooper; Preethi Eldi; Eri Nakayama; Kerrilyn R Diener; Paul M Howley; John D Hayball; Thomas E Morrison; Andreas Suhrbier
Journal:  NPJ Vaccines       Date:  2020-06-02       Impact factor: 7.344

5.  Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.

Authors:  Ianko D Iankov; Manoj Pandey; Mary Harvey; Guy E Griesmann; Mark J Federspiel; Stephen J Russell
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

6.  Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock.

Authors:  Penny A Rudd; Jane Wilson; Joy Gardner; Thibaut Larcher; Candice Babarit; Thuy T Le; Itaru Anraku; Yutaro Kumagai; Yueh-Ming Loo; Michael Gale; Shizuo Akira; Alexander A Khromykh; Andreas Suhrbier
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

7.  Characterization of the B-cell immune response elicited in BALB/c mice challenged with Neospora caninum tachyzoites.

Authors:  Luzia Teixeira; Andreia Marques; Carla Sofia Meireles; Ana Rita Seabra; Diana Rodrigues; Pedro Madureira; Augusto M R Faustino; Carolina Silva; Adília Ribeiro; Paula Ferreira; José Manuel Correia da Costa; Nuno Canada; Manuel Vilanova
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

8.  Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice.

Authors:  Vivian V Costa; Caio T Fagundes; Deborah F Valadão; Thiago V Ávila; Daniel Cisalpino; Rebeca F Rocha; Lucas S Ribeiro; Fernando R Ascenção; Lucas M Kangussu; M Q Celso; Ruiz G Astigarraga; Frederico L Gouveia; Tarcília A Silva; Daniela Bonaventura; Divaldo de Almeida Sampaio; Ana Cristina L Leite; Mauro M Teixeira; Danielle G Souza
Journal:  Med Microbiol Immunol       Date:  2014-04-11       Impact factor: 3.402

9.  Neutralization capacity of measles virus H protein specific IgG determines the balance between antibody-enhanced infectivity and protection in microglial cells.

Authors:  Ianko D Iankov; Alan R Penheiter; Guy E Griesmann; Stephanie K Carlson; Mark J Federspiel; Evanthia Galanis
Journal:  Virus Res       Date:  2012-12-21       Impact factor: 3.303

Review 10.  Arthritogenic alphaviruses--an overview.

Authors:  Andreas Suhrbier; Marie-Christine Jaffar-Bandjee; Philippe Gasque
Journal:  Nat Rev Rheumatol       Date:  2012-05-08       Impact factor: 20.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.